Inactive Instrument
Cann American Corp. Stock Other OTC
Stocks
CNNA
US13764N2071
Pharmaceuticals
OTC Markets Traded| Market Cap | 1.77M 1.53M 1.43M 1.31M 2.47M 169M 2.51M 16.78M 6.59M 84.47M 6.65M 6.5M 279M | P/E 2022 |
0.12x | P/E 2023 | 0.19x |
|---|---|---|---|---|---|
| Enterprise Value | 2.08M 1.8M 1.68M 1.54M 2.9M 198M 2.95M 19.73M 7.74M 99.31M 7.82M 7.65M 328M | EV / Sales 2022 |
-
| EV / Sales 2023 | - |
| Free-Float |
99% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | +4.97% |
| Manager | Title | Age | Since |
|---|---|---|---|
Jason Tucker
CEO | Chief Executive Officer | - | 01/02/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Jason Tucker
BRD | Director/Board Member | - | 01/02/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.97% | +24.45% | - | - | 4.43M | |
| -0.52% | +3.21% | +89.52% | +127.32% | 1,057B | |
| +0.88% | +1.13% | +49.56% | +49.69% | 625B | |
| +0.89% | -1.95% | +24.23% | +64.44% | 435B | |
| +0.71% | +3.87% | +49.07% | +37.85% | 363B | |
| +0.64% | -0.49% | +33.94% | +40.01% | 296B | |
| +0.39% | -5.83% | +8.92% | +7.85% | 249B | |
| +1.51% | +6.69% | +42.58% | +57.57% | 222B | |
| +3.92% | -0.46% | -5.56% | -52.32% | 209B | |
| +1.80% | +2.30% | +11.56% | +66.35% | 165B | |
| Average | +1.52% | +0.87% | +33.76% | +44.31% | 402.31B | |
| Weighted average by Cap. | +0.66% | +1.22% | +48.72% | +64.63% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | - | - |
| Net income | 10.54M 9.12M 8.52M 7.81M 14.69M 1B 14.93M 99.9M 39.21M 503M 39.58M 38.72M 1.66B | 3.82M 3.31M 3.09M 2.83M 5.33M 364M 5.41M 36.22M 14.22M 182M 14.35M 14.04M 603M |
| Net Debt | 202K 175K 163K 150K 281K 19.21M 286K 1.91M 751K 9.63M 758K 741K 31.83M | 311K 269K 251K 231K 434K 29.61M 440K 2.95M 1.16M 14.84M 1.17M 1.14M 49.06M |
Employees
-
Sector
Pharmaceuticals
